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Regulation of endothelin synthesis by extracellular matrix in progressively recognized [1–3]. With regards to tissue
human endothelial cells. perfusion, endothelial dysfunction could be defined as
Background. Vascular diseases are characterized by the an abnormal pattern of endothelial vasoactive factor syn-presence of structural changes and the progressive loss of endo-
thesis, with the subsequent local hemodynamic derange-thelial function. Although the biochemical basis of these struc-
tural changes have started to be outlined, it seems that accumu- ment. Most of studies in this field have analyzed the
lation of normal extracellular matrix proteins as well as the vasodilator response to acetylcholine to explore endo-
appearance of interstitial collagens, mainly collagen type I, thelial dysfunction [4, 5]. Acetylcholine induces the syn-characterize this process. On the other hand, a role for endothe-
thesis of nitric oxide (NO) by endothelial cells, and alial vasoactive factors has been proposed in the genesis of
endothelial dysfunction, and it is generally accepted that defective vasodilator response after its administration
changes in extracellular matrix composition may modify cell points to an inadequate NO synthesis [6]. With this ap-
behavior. proach, the concept of endothelial dysfunction in vascu-Methods. Experiments were designed to test the influence
lar pathology has expanded. However, NO is not theof the supporting matrix on endothelin-1 (ET-1) synthesis by
only vasoactive metabolite synthesized by endothelialendothelial cells. Northern blot experiments were performed
to analyze the prepro-endothelin-1 (prepro-ET-1) mRNA ex- cells, and an increased endothelin synthesis or a de-
pression. ET-1 production was measured by ELISA. creased prostacyclin release, for instance, also could be
Results. Cells grown on collagen type I (Col I) showed an
involved in the maintenance of the abnormal endothelialincrease of prepro-ET-1 mRNA level when compared with
function. In this sense, a deranged synthesis of endo-cells cultured on collagen type IV (Col IV). According to these
results, the release of ET-1 to culture medium was also higher thelin has been demonstrated in different vascular dis-
in Col I-grown cells than in those cultured on Col IV. Treatment eases [7–9].
of cells with a peptide that interferes with Col I integrins (D6Y),
The mechanisms responsible for endothelial dysfunc-or with protein tyrosine kinase inhibitors such as genistein and
tion are incompletely known. The importance of me-herbimycin, completely abolished the effect of Col I. Moreover,
experiments with antibodies against integrins suggest that these chanical damage in hypertension, oxidized lipoproteins
cell surface receptors could be involved in the modulation of in atherosclerosis or the hyperglycemic environment in
ET-1 system by extracellular matrix. diabetes are the more easily understood, and they areConclusions. These results suggest that the presence of an
supported by wide experimental evidence [10–12]. How-abnormal extracellular matrix could stimulate endothelin syn-
thesis by human endothelial cells, through integrin activation. ever, most authors agree that the pathogenesis of endo-
thelial dysfunction is a multifactorial phenomenon, and
alternative pathways are being explored. For example,
The role of endothelial dysfunction in the pathogene- reactive oxygen species (ROS) seem to be one of these
sis of tissue damage in several vascular diseases, includ- pathogenic factors [13–15].
ing hypertension, atherosclerosis or diabetes has been The present experiments analyzed alternative mecha-
nisms in the genesis of endothelial dysfunction. Our hy-
pothesis was based in two major facts. First, damagedKey words: endothelial dysfunction, tyrosine kinase, integrin, vascular
disease, extracellular matrix, tissue damage. vascular structures undergo significant structural changes,
with an increased cell proliferation and an accumulation
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abnormal ECM proteins may induce profound effects Cell culture
on cell behavior [18–21]. Human endothelial cells from umbilical vein (HUVEC)
Extracellular matrix proteins interact with cells were obtained and cultured as described previously [25].
through transmembrane heterodimeric proteins named Cells were seeded on dishes coated with gelatin 0.2% at
integrins [22, 23]. They are formed by two subunits, alpha 37C in a humidified atmosphere of 95C air and 5%
and beta chains, which depend on the cell type [24]. As CO2. Individual clones were established and subcloned
a consequence of the interaction, intracellular kinases to obtain pure cell populations. Clones were character-
are activated and a complex intracellular response devel- ized by their typical cobblestone morphology, by the
presence of factor VIII-related antigen and by the uni-ops, inducing profound changes in cell function. The best
form uptake of fluorescent acetylated low-density lipo-known kinases involved in cell responses after a matrix
protein (LDL), as described [25]. Cells were fed everyto cell interaction include a group of tyrosine kinases,
two days with M-199 medium supplemented with 20%such as focal adhesion kinase (FAK) [22, 24].
FCS, 100 U/mL penicillin, 100 g/mL streptomycin, 2Taking this information into account, we tested the
mmol/L l-glutamine, 20 mmol/L HEPES and 300 g/mLhypothesis that the presence of increased amounts of
EGF. Cells were passaged every five to seven days withabnormal ECM proteins in vessel walls could induce phe-
trypsin-EDTA and grown on collagen type IV and colla-notypic changes in endothelial cells with the subsequent
gen type I coated culture plates (12.5 g/mL), as de-modifications in the patterns of local synthesis of bioactive
scribed (two-dimensional cultures) [26], as well as onmediators, that is, endothelial dysfunction and the mainte-
gelatin for control purposes. Studies were routinely per-nance of vascular injury. In a more strict sense, we were
formed on confluent monolayers five to seven days afterconcerned about the possibility that endothelin synthesis
passage, at passages 2 to 4. Toxicity was evaluated in anyby endothelial cells could change in presence of collagen
experimental condition by the trypan blue dye exclusionI, and so we wanted to determine the possible mechanisms
method.involved. As an in vitro experimental approach, human
umbilical vein endothelial cells (HUVEC) grown on colla- Analysis of mRNA expression
gen I and collagen IV coated dishes were used. Total cellular RNA was isolated by the guanidinium
lysis method in confluent monolayers of HUVEC grown
on both collagen types, after 24 hours of serum depriva-METHODS
tion under different experimental conditions [27]. For
Materials Northern analysis, 10g samples of RNA were subjected
Collagen types I and IV, endothelial cell growth factor to electrophoresis in 1% agarose gels containing 0.66
(EGF), salmon sperm DNA, formaldehyde, guanidinium mol/L formaldehyde and transferred to nylon filters as
thiocyanate, formamide, genistein, actinomycin D, endo- described [27]. Filters were dried at 80C for two hours
thelin-1 (ET-1) and herbimycin were purchased from and UV cross-linked. Filters were blocked by incubation
in a prehybridization solution [50% formamide, 5Den-Fluka-Sigma (St. Louis, MO, USA). M-199 medium, fe-
hardt’s solution, 5  sodium chloride sodium phosphatetal calf serum (FCS), trypsin-ethylenediaminetetraacetic
EDTA (SSPE), 0.5% sodium dodecyl sulfate (SDS) andacid (trypsin-EDTA; 0.02%), l-glutamine, HEPES and
100 to 200 g salmon sperm DNA solution] at 42C forpenicillin-streptomycin were obtained from BioWhit-
three hours and probed overnight at 42C with 32P-labeledtaker (Walkersville, MD, USA). Culture plates were
human preproendothelin-1 (1.2 kb fragment; ATCC,from Nunc (Kamstrup, Denmark). The random prime
Rockville, MD, USA) cDNA probe. Filters then werelabeling system (Rediprime II), nylon filters (Hybond N),
washed in medium stringency conditions [0.2  standardand deoxy-[32P] cytidine triphosphate were purchased
sodium citrate (SSC), 0.5% SDS, 30 min at 45C], andfrom Amersham Pharmacia Biotech (Buckinghamshire,
then, exposed to X-OMAT film. Autoradiographs were
UK). Endothelin-1 ELISA was from Promega (Ref.
performed at 80C using intensifying screens and were
G-1250; Madison, WI, USA). X-OMAT films were from developed after 24 hours. Filters were stripped by boiling
Kodak (Rochester, NY, USA). The bicinchoninic acid in 0.1% SDS solution and reprobed with glyceraldehyde-
(BCA) assay kit was from Pierce (Rockford, IL, USA). 3-phosphate dehydrogenase (GAPDH) or 28S cDNA
Human prepro-endothelin-1 cDNA probe was supplied probe, in order to obtain a housekeeping control for both
by American Type Culture Collection (Rockville, MD, load and specificity of gene expression. Levels of prepro-
USA). D6Y peptide (Asp-Gly-Gly-Arg-Tyr-Tyr) was endothelin-1 (prepro-ET-1) mRNA were normalized us-
supplied by Neosystem (Strasbourg, France). Specific ing GAPDH or 28S expression. The densitometric analy-
antibodies against 1, 2, 3 and 1 integrins were pro- sis of the films was performed with an Apple scanner
vided by F. Sanchez Madrid (Dept. of Immunology, Hos- and appropriate software (NIH image from the National
Institutes of Health).pital de la Princesa, Madrid, Spain).
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Measurement of endothelin-1 in incubation media
Confluent monolayers of HUVEC cultured on colla-
gen type IV (Col IV) and collagen type I (Col I) were
maintained in serum-free medium for 24 hours under
different experimental conditions. After this period, su-
pernatants were collected, lyophilized, and stored at
70C. Endothelin-1 (ET-1) was measured by ELISA.
The intracellular endothelin content was checked by
scraping the cells after 24 hours of serum deprivation.
Suspensions were sonicated and processed as cellular
supernatants.
Statistical methods
Results are expressed as the mean SEM of a variable
number of experiments (defined in the Figure legends).
As the number of experiments was under 10 in some
cases, non-parametric statistics were used for group com-
parisons. Friedman test was selected, taking as reference
the control sample performed in the same day. A P 
0.05 was considered statistically significant.
RESULTS
Endothelial cells grown on Col I showed higher pre-
pro-ET-1 mRNA expression than those in contact with
Col IV (Fig. 1). In Figure 1A, the Northern blot results
of two different preparations can be observed, as well
as the mean values of the Col I-induced changes in the
mRNA steady state levels of prepro-ET-1. The increase
was over twofold. The release of endothelin-1 to culture
Fig. 1. Effect of cell culture on collagen type I (Col I) on the endothe-
medium in the same culture conditions also was evalu- lial-1 (ET-1) system. Analysis of the steady-state prepro-endothelin-1
(Prepro-ET-1) mRNA levels. Results are compared with those fromated and the results appear Figure 1, B and C. Cells
cells cultured on collagen type IV (Col IV) and gelatin (Gel). (A) Acultured on Col I released more ET-1 to culture medium
representative Northern blot experiment is shown. In the lower panel,
than those grown on Col IV. No significant ET-1 storing the ratios between the PreproET-1 mRNA and a housekeeping gene
mRNA expression are reflected. Results are expressed as percent oftook place in cells grown in the two conditions tested
the Col IV values. (B) Basal ET-1 production in cells cultured on the(intracellular immunoreactive ET-1 for Col IV 0.7 0.1,
two matrices tested, and on gelatin. Results are expressed as percent
and Col I 0.9  0.2 fmol/well). Moreover, no differences of Col IV values (132  25 nmol/mg protein). In every case, results are
the mean SEM of a variable number of experiments (12 for collagenswere found in the degree of confluence of cells, in both
and 4 for gelatin). *P  0.05 vs. Col IV.kind of matrix, as assessed by direct observation and
protein measurements (Col IV 187  17, Col I 199 
21 g/well). For control purposes, gelatin-grown cells
also were studied. As shown in the Figure 1, the prepro- tested at several levels. First, the possible role played by
the interaction of Col I with specific membrane proteinsET-1 mRNA expression and ET-1 synthesis were compa-
rable in Col I and gelatin cells, with similar degrees of of the integrin family was tested with Asp-Gly-Gly-Arg-
Tyr-Tyr (D6Y), an oligopeptide that blocks the Colcell confluence (Col I 190  15 g/well; gelatin 192 
11 g/well). I-dependent effects in some cell types [28]; the results are
in Figure 3. Incubation with increasing concentrations ofThe relative contributions of an increased gene tran-
scription or a stabilization of the mRNA to the Col D6Y progressively inhibited the increased prepro-ET-1
mRNA expression elicited by Col I (Fig. 3A). AccordingI-dependent effects was tested, and the results are in
Figure 2. Actinomycin D (Act D), an RNA synthesis to this finding, the increase in the ET-1 production in-
duced by Col I also was blocked by the incubation withinhibitor, completely blunted the prepro-ET-1 mRNA
differences observed between both collagens (Fig. 2A). D6Y (Fig. 3 B, C). In both cases, a complete inhibition
was observed from 50 mol/L D6Y. Lower doses ofIn fact, no changes in the prepro-ET-1 mRNA stability
were detected in the two matrices tested (Fig. 2B). D6Y did not modify cell adherence, but a slight cell
detachment was observed with 100 mol/L D6Y (pro-The mechanisms involved in the effects of Col I were
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Fig. 2. Analysis of the mechanisms involved in the collagen I-increased
steady state prepro-endothelin-1 (Prepro-ET-1) mRNA levels. (A) Cul-
tured cells in both matrices were incubated for 24 hours with 10 g/mL
actinomycin D (Act D; ). *P  0.05 vs. values on Col IV; **P  0.05
vs. values without Act D () (Friedman and Wilcoxon tests). (B)
Prepro-ET-1 mRNA expression of Col IV () and Col I () after
different incubation times with Act D. In both panels, values are pre-
proET-1/28S RNA ratios after densitometric analysis, and are the mean
of 5 experiments expressed as absolute values (panel A) or as percent
of control values (C).
Fig. 3. Modulation of the effects of collagen type I (Col I) on thetein/well g/well: Col IV 201  15; Col I 191  14 g/
endothelin-1 (ET-1) system by a peptide that blocks the interactionswell; 25 mol/L D6Y 	 Col I 205  18; 50 mol/L
of Col I with integrins (D6Y). (A) Prepro-ET-1 mRNA expression was
D6Y 	 Col I 196  13; 100 mol/L D6Y 	 Col I 167  analyzed in cells cultured on Col I and incubated with different D6Y
(Asp-Gly-Gly-Arg-Tyr-Tyr) concentrations for 24 hours. Results are11*; *P  0.05 vs. the other groups). Second, experi-
compared with those from cells cultured on Col I and Col IV. A repre-ments with antibodies that are able to block different
sentative Northern blot experiment is shown in the upper gels, and
integrins expressed in endothelial cells supported the in the lower part, the ratios between the prepro-ET-1 mRNA and a
housekeeping gene mRNA expression are reflected. Results are ex-role of these transmembrane proteins in the effects of
pressed as percent of the Col IV values. (B and C ) Modulation of Col ICol I on the ET-1 system (Fig. 4). The anti-3 antibody effects on ET-1 synthesis with D6Y, used as described. Results are
was the most powerful inhibitor of the stimulatory signal expressed as a percent of the Col IV values (151 11 nmol/mg protein).
In every case, results are the mean  SEM of 4 different experiments.of Col I, whereas anti-1 only induced a minimal inhibi-
*P  0.05 vs. the other values.tion. Third, the importance of tyrosine kinase activation
was analyzed with two pharmacological antagonists of
the system: genistein and herbimycin. These tyrosine
kinase inhibitors completely prevented the stimulatory the culture media increased in cells seeded on Col I,
when compared with cells on Col IV. Moreover, theeffect of Col I on the prepro-ET-1 expression as well as
results suggest that these differences were not the conse-on the ET-1 production (Fig. 5).
quence of changes in prepro-ET-1 mRNA stability, and
they point to the possibility that different ECM proteins
DISCUSSION could differentially modulate the expression of this
Our results highlight the importance of an abnormal mRNA. By comparing the two cultures, no significant
ECM protein to modulate the pattern of synthesis of morphological differences were detected by direct cell
vasoactive factors by cultured endothelial cells. Both the observation, the protein content was comparable, and
no significant cell toxicity was apparent. The control ofprepro-ET-1 mRNA expression and the ET-1 release to
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Fig. 4. Modulation of the effects of Col I on the ET-1 system by
antibodies against integrins. Confluent HUVEC cultured on both colla-
gen types [() Col IV; () Col I], were incubated for 24 hours with
specific antibodies against 1, 2, 3 and 1 integrins. After this period,
endothelin concentrations in the supernatants were measured by
ELISA. Results are expressed as percent of the basal Col IV values
(141  9 nmol/mg protein), and they are the mean  SEM of 5 experi-
ments. *P  0.05 vs. Col IV without antibodies. **P  0.05 vs. Col I
without antibodies.
cell confluence was especially important, as it has been
demonstrated that the mRNA stability of endothelial
nitric oxide synthase (eNOS) may be modified by this
parameter [29]. Consequently, it seems that the different
nature of the culture substrate was responsible for the
differences observed.
Significant quantitative differences were observed
when considering the Col I-dependent changes in pre-
pro-ET-1 mRNA expression (about twofold) and ET-1
protein synthesis (about 25%). The present experimental
design did not extensively evaluate the mechanisms re-
sponsible for this difference, but various possibilities
could be proposed. For instance, the synthesis of ET-1
Fig. 5. Modulation of the effects of Col I on the ET-1 system by tyrosinefrom prepro-ET-1 involves two enzymatic cleavages, and kinase inhibitors. (A) Prepro-ET-1 mRNA expression was analyzed in
extracellular matrix also may regulate these activities. cells cultured on Col I and incubated with 2 mol/L genistein (GN) or
1 mol/L herbimycin (Herb) for 24 hours. Results are compared withEndothelial cells interact with different ECM proteins
those from cells cultured on Col I and Col IV. In the upper part of thethrough integrins. It seems that the different collagen panel, a representative Northern blot experiment is shown, and the
types are recognized by heterodimeric complexes of 1, lower part reflects the ratios between the prepro-ET-1 mRNA and a
housekeeping gene mRNA expression. Results are expressed as percent2 or 3 with 1 [30, 31], whereas V1 is used preferen-
of the Col IV values. (B and C ) Modulation of collagen-I effects on ET-1tially for fibronectin interactions [32]. The possibility that synthesis with GN or Herb, used as described. Results are expressed as
the differential activation of these integrins could be percent of the Col IV values (159  14 nmol/mg protein). In every
case, results are the mean  SEM of a variable number of experimentsresponsible for the observed differences between the two
(8 for GN and 4 for Herb). *P  0.05 vs. the other groups.collagen types was tested by two means. First, a peptide
capable of blocking the integrin-mediated Col I-depen-
dent cellular effects but not cell adhesion, D6Y [28], was
used. As shown in the Results section, this peptide com- was the same in every case, the interpretation of these
pletely abolished the changes in ET-1 elicited by Col I. quantitative differences must be performed cautiously,
Second, different specific antibodies were used. Again, as no controls of the antibody blocking activity or the
the Col I-dependent stimulation on ET-1 synthesis was integrin cell surface expression were performed. Never-
blocked but differences were detected with respect to theless, the results suggest that the 31 integrin could
the intensity of the blockade. Anti-3 antibody was the play a significant role in the Col I-dependent increased
most powerful inhibitor of the effects of collagen I, fol- ET-1 synthesis.
lowed by anti-2 and anti-1 antibodies, and finally The D6Y and the antibody experiments provide addi-
tional information. They stress the specific nature of theanti-1 antibody. Although the antibody concentration
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